Bradykinin metabolism in rat hind limbs

Shock

Volumn 10, Issue 2, 1998, Pages 146-152

  Griswold, John A ^a   Baker Jr , C R F ^a   Little, Donnie T ^a   Little, Gwynne H ^a   Behal, Francis J ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ (1 5); BRADYKININ (1-5); DIPEPTIDE; PEPTIDE FRAGMENT;

ANIMAL; ARTICLE; CHEMISTRY; HINDLIMB; KINETICS; LIVER; LUNG; MALE; METABOLISM; PERFUSION; RAT; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; BRADYKININ; DIPEPTIDES; HINDLIMB; KINETICS; LIVER; LUNG; MALE; MUSCLE, SKELETAL; PEPTIDE FRAGMENTS; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032135036     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199808000-00011     Document Type: Article

References (31)

1. Baker CRF, Little AD, Little GH, Canizaro PC, Behal FJ: Kinin metabolism in the perfused ventilated rat lung. I. Bradykinin metabolism in a system modeling the normal, uninjured lung. Circ Shock 33:37-47, 1991.
2. Baker CRF, Little AD, Beall CV, Little GH, Canizaro PC, Behal FJ: Kinin metabolism in the perfused ventilated rat lung. JJ. Influence of ventilation, perfusion and perfusate composition variation of bradykinin metabolism in uninjured lung. Circ Shock 37:280-290, 1992.
3. Beall CV, Baker CR, Griswold J, Little AD, Little GH, Behal FJ: The effect of smoke inhalation on bradykinin metabolism by the perfused and ventilated rat lung. J Burn Care Rehab 16:487-495, 1995.
4. Griswold JA, Beall CV, Baker CRF, Little DT, Little GH, Behal FJ: Bradykinin metabolism in the liver and lung of the rat. J Surg Res 66:12-20, 1996.
5. Movat HZ: The plasma kallikrein-kinin system and its interrelationship with other components of blood. In Erdos EG (ed): Bradykinin, kallidin, and kallikrein. Berlin, Heidelberg, New York: Springer Verlag, 1979, pp 1-2.
6. Bogle RG, Coade SB, Moncada S, Pearson JD, Mann GE: Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem Biophys Res Comm 180:926-932, 1991.
7. Vallance P, Patton S, Bhagat K, MacAllister R, Radomski M, Moncada S, Malinski T: Direct measurement of nitric oxide in human beings. The Lancet 346:153-154, 1995.
8. Tiffany CW, Burch RM: Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Letters 47:189-192, 1989.
9. Holland JA, Pritchard KA, Pappolla MA, Wolin MS, Rogers NJ, Stemerman MB: Bradykinin induces superoxide anion release from human endothelial cells. J Cell Physiol 143:21-25, 1990.
10. Szechinkski J, Hsia W, Behal FJ: A kininase and a kinin-converting enzyme: Two distinct alpha aminoacyl peptide hydrolases from bovine lung. Enzyme 29:21-31, 1983.
11. Sidorowicz W, Szechinski J, Canizaro PC, Behal FJ: Cleavage of Arg-Pro bond of bradykinin by human lung peptidase: Isolation, characterization and inhibition by β-lactam antibiotics. Proc Soc Exp Biol Med 175:503-509, 1984.
12. Heins J, Neubert K, Barth A, Canizaro PC, Behal FJ: Kinetic investigation of the hydrolysis of aminoacylprolyl p-nitroanilides by dipeptidyl-peptidase-IV from human and pig kidney. Biochim Biophys Acta 785:30-35, 1984.
13. Zolfaghari R, Baker CRF, Canizaro PC, Feola M, Amirgholami A, Behal FJ: Human lung post proline endopeptidase: Purification and action on vasoactive peptides. Enzyme 36:165-178, 1986.
14. Zolfaghari R, Baker CRF, Canizaro PC, Amirgholami A, Behal FJ: High-molecular-mass neutral endopeptidase-24.5 from human lung. Biochem J 241:129-135, 1987.
15. Zolfaghari R, Little D, Baker CRF, Canizaro PC, Behal FJ: Human lung membrane-bound neutral metalloendo-peptidase catalyzed hydrolysis of bradykinin. Enzyme 42:160-173, 1989.
16. Kitamura S, Carbini LA, Carretero OA, Simmons WH, Scicli AG: Potentiation by aminopeptidase-P of blood pressure response to bradykinin. Brit J Pharmacol 114:6-7, 1995.
17. Hecker M, Fleming I, Busse R: Kinin-mediated activation of endothelial NO formation: Possible role during myocardial ischemia. Agents Actions Suppl 45:119-127, 1995.
18. Linz W, Wiemer G, Schoelkens BA: Cardioprotective actions of bradykinin in myocardial ischemia and left ventri cular hypertrophy. Brazilian J Med Res 27:1949-1954, 1994.
19. Rubin LE, Levi R: Protective role of bradykinin in cardiac anaphylaxis. Circ Res 76:434-440, 1995.
20. Piedimonte G, Nadel JA, Long CS, Hoffman JIE: Neutral endopeptidase in the heart. Circ Res 75:770-779, 1994.
21. Nossaman BD, Kaye AD, Feng CJ, Kang B, Kadowitz J: Analysis of responses to bradykinin in the rat hindquarters vascular bed. Amer J Physiol 272:R631-R639, 1997.
22. Ward PE, Russell JS, Vaghy PL: Angiotensin and bradykinin metabolism by peptidases identified in skeletal muscle. Peptides 16:1073-1078, 1995.
23. Wangensteen OD, Lysaker F, Savaryn P: Pulmonary capillary filtration and reflection coefficients in the adult rabbit. Microvasc Res 14:81-87, 1977.
24. Skeggs LT, Dorer FE, Kahn JR, Lentz KE, Levine M: Experimental Renal Hypertension: The Discovery of the Renin-Angiotensin System. In Soffer RL (ed): Biochemical Regulation of Blood Pressure. New York, Chicester, Brisbane, Toronto: John Wiley & Sons, 1981, pp 1-38.
25. Dendorfer A, Wolfrum S, Wellhoner P, Korsman K, Dominiak P: Intra-vascular and intersitial degradation of bradykinin in isolated perfused rat heart. Brit J Pharmacol 122:1179-1187, 1997.
26. Sakakibara T, Hintze TH, Nasjlettt A: Determinants of kinin release in isolated rat hindquarters. Am J Physiol 274:R120-R125, 1998.
27. Klausner JM, Paterson IS, Mannick JA, Valeri R, Shepro D, Hechtman HB: Reperfusion pulmonary edema. JAMA 261:1030-1035, 1989.
28. Anner H, Kaufman RP, Valeri CR, Shepro D, Hechtman HB: Reperfusion of ischemic lower limbs increases pulmonary microvascular permeability. J Trauma 28:607-610, 1988.
29. Anner H, Kaufman R, Kobzik L, Valeri CR, Shepro D, Hechtman HB: Pulmonary hypertension and leucosequestration after lower torso ischemia. Ann Surg 206:642-648, 1987.
30. Doukas J, Hechtman HB, Shepro D: Endothelial-secreted arachidonic acid metabolites modulate polymorphonuclear leukocyte chemotaxis and diapedesis in vitro. Blood 71:771-779, 1988.
31. 2 mediates augmented polymorphonuclear leukocyte adhesiveness. J Clin Invest 66: 406-414, 1980.